News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zydus Pharmaceuticals (USA) Inc. Selects Revitas™ Flex™ Platform to Support Growth Model



5/3/2012 10:26:47 AM

PHILADELPHIA--(BUSINESS WIRE)--Revitas announced today that Zydus Pharmaceuticals USA, Inc., a globally integrated generic pharmaceutical company, has selected the strategic Revitas™ Flex™ technology platform to support the company’s rapid growth for its US operations. As a generic-only pharmaceutical company, Zydus has chosen the Flex platform to manage contracts, optimize pricing, and ensure compliance through Revitas’s Enterprise Revenue Dynamics (ERD) solutions.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES